The World Health Organisation said on Wednesday that testing of the malaria drug hydroxychloroquine in its large multi-country trial of treatments for COVID-19 patients had been halted after results from other trials showed no benefit, reports Reuters.
"The hydroxychloroquine arm of the SOLIDARITY trial has been stopped," WHO expert Ana Maria Henao-Restrepo told a news briefing.